Matthew Cunningham
About Matthew Cunningham
Matthew Cunningham is a Medical Device Toxicologist II at Boston Scientific, specializing in chemical safety assessments and biocompatibility testing.
Current Position at Boston Scientific
Matthew Cunningham currently holds the position of Medical Device Toxicologist II at Boston Scientific in St Paul, Minnesota. He has been in this role since 2020. In this capacity, he develops and authors Chemical Safety Assessments and toxicology memos to support divisional objectives. He also consults and advises biocompatibility specialists on the development of test plans and provides input on regulatory requirements for medical device submissions.
Previous Experience at American Preclinical Services
Matthew Cunningham has had extensive experience at American Preclinical Services, LLC, where he served in multiple roles. Starting as an Animal Technician in 2014, he then transitioned into several other roles including Laboratory Technician, Associate Scientist, and Scientist. Over his tenure from 2014 to 2020, he gained comprehensive experience in toxicology and in-vitro testing, contributing to various projects in Coon Rapids, MN.
Educational Background
Matthew Cunningham studied at the University of Minnesota, where he earned a Bachelor's degree in Biology. From 2010 to 2014, he gained foundational knowledge that has been crucial in his career as a toxicologist. His studies included a broad range of biological sciences, providing him with the skills and expertise needed for his roles in medical device toxicology and biocompatibility assessments.
Responsibilities at Boston Scientific
In his role at Boston Scientific, Matthew Cunningham is responsible for providing input on regulatory requirements related to medical device submissions. He also serves as a resource for information on biocompatibility and toxicology, particularly focusing on issues related to materials of animal origin and colorant additives. Additionally, he supports problem-solving and resolution related to chemical risk assessments and biocompatibility assessments.
Contributions to Strategic Device Development Programs
Matthew Cunningham has made significant contributions to Boston Scientific's strategic device development programs. His work includes biocompatibility, chemistry, and toxicology testing related to new investigational devices. This involvement ensures that new medical devices meet safety standards and regulatory requirements before they reach the market.